Candel Therapeutics Ownership & Insider Activity

Candel Therapeutics (CADL) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 6.1% of shares outstanding. Institutional investors hold 42.0%. Over the past 90 days, insiders made 2 sales worth $3.1M.

Shares Outstanding

76.519M

Shares Float

59.510M

Insider Shares Owned

4.682M

Insider % Owned

6.1%

Institutional Shares Held

32.138M

Institutional % Held

42.0%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

Sales (90d)

$3.1M total

Net Activity

Net Selling

Net Value (90d)

-$3.1M

Candel Therapeutics Insider Transactions (Last 6 Months)

Date	Insider	Title	Type	Shares	Price	Value
Sep 10, 2026	Paul Peter Tak	CHIEF EXECUTIVE OFFICER	SELL	155.245K	$6.41	$3.0M
Aug 17, 2026	Seshu Tyagarajan	CHIEF TECHNOLOGY OFFICER	SELL	7.000K	$12.00	$84K
Jun 29, 2026	Francesca Barone	CHIEF SCIENTIFIC OFFICER	SELL	23.447K	$10.06	$236K
Jun 29, 2026	Seshu Tyagarajan	CHIEF TECHNOLOGY OFFICER	SELL	7.000K	$10.02	$70K